Biblio

Author Title [ Type(Desc)] Year
Filters: Author is Maguire, Jean Ann  [Clear All Filters]
Journal Article
Liao C-M, Mukherjee S, Tiyaboonchai A, Maguire JAnn, Cardenas-Diaz FL, French DL, Gadue P. GATA6 suppression enhances lung specification from human pluripotent stem cells. J Clin Invest. 2018.
Gagne AL, Maguire JAnn, Gandre-Babbe S, Chou ST, Tasian SK, Loh ML, Weiss MJ, Gadue P, French DL. Generation of a human Juvenile myelomonocytic leukemia iPSC line, CHOPi001-A, with a mutation in CBL. Stem Cell Res. 2018;31:157-160.
Wilken MB, Maguire JAnn, Dungan LV, Gagne A, Osorio-Quintero C, Waxman EA, Chou ST, Gadue P, French DL, Thom CS. Generation of a human Tropomyosin 1 knockout iPSC line. Stem Cell Res. 2023;71:103161.
Hashmi SK, Schneider S, Gagne AL, Maguire JAnn, Anderson S, Gadue P, Heuckeroth RO, French DL. Generation of CHOPe003-A ESC line to study an ACTG2 variant affecting smooth muscle development and function. Stem Cell Res. 2023;71:103186.
Cardenas-Diaz FL, Maguire JAnn, Gadue P, French DL. Generation of Defined Genomic Modifications Using CRISPR-CAS9 in Human Pluripotent Stem Cells. J Vis Exp. 2019;(151).
Mukherjee S, Gagne AL, Maguire JAnn, Jobaliya CD, Mills JA, Gadue P, French DL. Generation of human control iPSC line CHOPi004-A from juvenile foreskin fibroblast cells. Stem Cell Res. 2020;49:102084.
Maguire JAnn, Gagne AL, Gonzalez-Alegre P, Davidson BL, Shakkottai V, Gadue P, French DL. Generation of Spinocerebellar Ataxia Type 2 induced pluripotent stem cell lines, CHOPi002-A and CHOPi003-A, from patients with abnormal CAG repeats in the coding region of the ATXN2 gene. Stem Cell Res. 2018;34:101361.
Maguire JAnn, Gadue P, French DL. Highly Efficient CRISPR/Cas9-Mediated Genome Editing in Human Pluripotent Stem Cells. Curr Protoc. 2022;2(11):e590.
Dawicki-McKenna JM, Felix AJ, Waxman EA, Cheng C, Amado DA, Ranum PT, Bogush A, Dungan LV, Maguire JAnn, Gagne AL, et al. Mapping PTBP2 binding in human brain identifies SYNGAP1 as a target for therapeutic splice switching. Nat Commun. 2023;14(1):2628.
Pavani G, Klein JG, Nations CC, Sussman JH, Tan K, An HHyung, Abdulmalik O, Thom CS, Gearhart PA, Willett CMarie, et al. Modeling primitive and definitive erythropoiesis with induced pluripotent stem cells. Blood Adv. 2024.
Borst S, Nations CC, Klein JG, Pavani G, Maguire JAnn, Camire RM, Drazer MW, Godley LA, French DL, Poncz M, et al. Study of inherited thrombocytopenia resulting from mutations in ETV6 or RUNX1 using a human pluripotent stem cell model. Stem Cell Reports. 2021.
Wilken MB, Fonar G, Nations C, Pavani G, Tsao V, Garifallou J, Tober J, Bennett L, Maguire JAnn, Gagne A, et al. Tropomyosin 1 deficiency facilitates cell state transitions to enhance hemogenic endothelial cell specification during hematopoiesis. bioRxiv. 2023.
An HHyung, Gagne AL, Maguire JAnn, Pavani G, Abdulmalik O, Gadue P, French DL, Westhoff CMarie, Chou ST. The use of pluripotent stem cells to generate diagnostic tools for transfusion medicine. Blood. 2022.
Littleton SH, Trang KB, Volpe CM, Cook K, DeBruyne N, Maguire JAnn, Weidekamp MAnn, Hodge KM, Boehm K, Lu S, et al. Variant-to-function analysis of the childhood obesity chr12q13 locus implicates rs7132908 as a causal variant within the 3' UTR of FAIM2. Cell Genom. 2024:100556.